Year: 2025
Type: article
Abstract: 280-character social media summary (237 characters) Landmark TB trials, shaped by their time, offer important lessons about balancing study designs, ethics, inclusion, simplicity, safety, and reporting. Looking back shows us how far we have come and how much work remains to improve treatments for TB patients.
Source: CMI Communications
Authors: Victor Naestholt Dahl, Nils Wetzstein
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,520
OpenAlex ID: W4413288706
